12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Infusion-related reactions (IRRs) in the DREAMM-2 Study of single-agent belantamab mafodotin (belamaf) in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nooka, A.; Lee, H. C.; Badros, A. Z.; Voorhees, P.; Hultcrantz, M.; Karlin, L.; Arnulf, B.; Richardson, P. G.; Zhi, E.; Baron, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center, dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of a novel IRAK4 inhibitor CA-4948 in combination with ibrutinib, in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Joffe, E.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Mead, M.; Landsburg, D. J.; Fenske, T. S.; Ramchandren, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Transcriptional control of HP1a by the RNA binding proteins RBMX/L1 maintain chromatin state in myeloid leukemia
    Meeting Abstract

    Nguyen, D. T. T.; Prieto, C.; Liu, Z.; Wheat, J.; Perez, A.; Gourkanti, S.; Chou, T.; Barin, E.; Chow, A.; Taggart, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Post-treatment clone size predicts survival independently of IPSS-R and response after azacitidine therapy for MDS
    Meeting Abstract

    Nannya, Y.; Tobiasson, M.; Sato, S.; Bernard, E.; Creignou, M.; Zhao, L.; Takeda, J.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Single-cell multi-omics in human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
    Meeting Abstract

    Nam, A. S.; Dusaj, N.; Izzo, F.; Murali, R.; Mouhieddine, T. H.; Myers, R. M.; Sotelo, J.; Benbarche, S.; Gaiti, F.; Tahri, S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • R-CHOP versus R-Bendamustine with or without rituximab maintenance in newly diagnosed follicular lymphoma patients with high SUV at baseline PET
    Meeting Abstract

    Mondello, P.; Strati, P.; Merryman, R. W.; Joffe, E.; Ruella, M.; Seshan, V.; St Pierre, F.; Major, A.; Pophali, P.; Fiasconaro, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interim positron emission tomography (iPET) assessed using Deauville score for patients with follicular lymphoma receiving first-line chemoimmunotherapy
    Meeting Abstract

    Merryman, R. W.; Spilberg, G.; Mondello, P.; Redd, R. A.; Taranto, E.; Ahmed, G.; Jeter, E.; Chase, M.; Salles, G.; Zelenetz, A. D.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and poor clinical outcome in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; more...
    Blood (2020)

    Fulltext@MSK | Save